French HTA Body Backs Routine Six-Week Interval In COVID-19 Vaccine Dosing
UK Expert Defends 12-Week Delay
France's health technology assessment body says that delaying by six weeks the second dose of the two mRNA vaccines approved for use against COVID-19 would allow at least 700,000 more people to receive their jab in the first month.
